Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
Peptide therapy is one of the fastest-growing areas of clinical medicine. From GLP-1 agonists for metabolic health to growth hormone secretagogues for recovery and body composition, peptides offer targeted interventions that work through the body’s own receptor systems. This guide covers what peptide therapy is, how it works, the major categories of peptides by goal, how to get started with a prescriber, what it costs, and how the regulatory landscape is evolving in 2026.
Peptides are short chains of amino acids — typically between 2 and 50 amino acids in length. They are found naturally throughout the body, acting as signaling molecules that tell cells what to do. Hormones like insulin, neurotransmitters, and growth factors are all peptides or contain peptide sequences.
Peptide therapy uses synthetic or bioidentical versions of these signaling molecules to target specific biological pathways. Unlike broad-spectrum medications that affect multiple systems, peptides are designed to bind to particular receptors — such as GLP-1 receptors for blood sugar regulation, ghrelin receptors for growth hormone release, or melanocortin receptors for sexual function.
The field has a history stretching back decades. Insulin, arguably the most well-known peptide drug, has been used since the 1920s. Growth hormone releasing peptides were developed in the 1980s. The recent explosion in peptide therapy interest has been driven largely by GLP-1 agonists like semaglutide (Ozempic/Wegovy) and tirzepatide (Mounjaro/Zepbound), which have demonstrated significant effects on metabolic health and body composition in large clinical trials.
What distinguishes peptide therapy from traditional small-molecule drugs is specificity. Peptides interact with the body’s existing receptor systems rather than broadly suppressing or stimulating biochemical pathways. This targeted mechanism is why many peptides have favorable side-effect profiles compared to conventional pharmaceuticals — though they are not without risks, and proper medical supervision is essential.
Peptide therapy works by introducing exogenous peptides into the body that mimic or enhance the function of endogenous signaling molecules. These peptides bind to specific receptors on cell surfaces or within cells, triggering downstream biological responses — from hormone release to tissue repair to immune modulation.
The route of administration is a critical factor in how well a peptide works, because it determines bioavailability — how much of the administered dose actually reaches systemic circulation.
Subcutaneous Injection
Bioavailability: ~90-100%
The most common route for peptide therapy. A small insulin syringe (29-31 gauge) delivers the peptide into the fat layer beneath the skin, typically in the abdomen or thigh. High absorption with minimal degradation.
Intramuscular Injection
Bioavailability: ~90-100%
Less common for peptides than subcutaneous, but used for some formulations. Faster absorption than subcutaneous due to higher blood flow in muscle tissue.
Intranasal Spray
Bioavailability: ~10-30%
Used for brain-targeted peptides like Semax and Selank. The nasal mucosa provides direct access to the central nervous system, bypassing the blood-brain barrier to some extent.
Oral / Capsule
Bioavailability: ~1-10%
Most peptides are degraded by stomach acid and digestive enzymes, resulting in very low oral bioavailability. Exceptions include BPC-157 (studied orally for gut applications) and oral semaglutide (Rybelsus), which uses an absorption enhancer.
Topical / Transdermal
Bioavailability: Variable
Used primarily for skin-targeted peptides like GHK-Cu. Topical application delivers the peptide directly to the treatment area with limited systemic absorption.
Sublingual
Bioavailability: ~10-25%
Some peptides are formulated as sublingual troches or drops. Absorption through the oral mucosa bypasses first-pass liver metabolism, offering better bioavailability than swallowed capsules.
Because of the bioavailability differences, most peptide therapy protocols use subcutaneous injection as the default route. Peptides arrive as lyophilized (freeze-dried) powder that must be reconstituted with bacteriostatic water before injection. For a step-by-step walkthrough of this process, see our reconstitution guide and dosing calculator.
Peptides are typically categorized by the biological system they target. Below are the major categories, with links to our in-depth category pages and guides.
Peptides like BPC-157 and TB-500 are studied for tissue repair, gut lining integrity, tendon and ligament recovery, and modulation of inflammatory markers like CRP and IL-6.
GLP-1 receptor agonists (semaglutide, tirzepatide) and mitochondrial peptides (MOTS-C) are the most studied compounds for metabolic regulation, appetite control, and body composition.
Growth hormone secretagogues like CJC-1295/Ipamorelin stimulate the body's natural GH release, which research has linked to improvements in lean body mass, recovery time, and sleep quality.
Nootropic peptides like Semax and Selank are derived from endogenous regulatory peptides and have been studied for their effects on BDNF, NGF, and monoamine neurotransmitter systems. Several are approved in Russia for anxiety and stroke recovery.
Thymic peptides like Thymosin Alpha-1 are studied for T-cell maturation, dendritic cell function, and cytokine modulation. Thymosin Alpha-1 is approved in over 35 countries as an immune adjuvant.
Peptides targeting the hypothalamic-pituitary axis — including GnRH analogs and growth hormone secretagogues — are studied for their effects on testosterone, growth hormone, and overall endocrine balance.
Longevity peptides like Epithalon target telomerase activation and pineal function, while copper peptides like GHK-Cu are studied for collagen synthesis and skin remodeling.
Sleep-regulatory peptides like DSIP modulate delta wave activity and HPA axis function. Unlike sedatives, these compounds work through neuroendocrine pathways to influence sleep architecture.
Starting peptide therapy requires three things: a qualified prescriber, a reputable pharmacy, and baseline lab work. Here is how the process typically works.
Find a prescriber
Peptide therapy requires a prescription from a licensed healthcare provider — a physician (MD/DO), nurse practitioner (NP), or physician assistant (PA). Look for providers who specialize in functional medicine, anti-aging medicine, or integrative health, as they are most likely to have experience with peptide protocols. Many peptide-focused clinics offer telemedicine consultations.
Get baseline labs
Before starting any peptide protocol, your prescriber will order lab work to establish baselines and rule out contraindications. The specific panel depends on the peptide — metabolic panels for GLP-1 agonists, IGF-1 for growth hormone secretagogues, inflammatory markers for recovery peptides. These labs also serve as the benchmark against which your prescriber will measure your response.
Choose a pharmacy
Your prescriber will send the prescription to a compounding pharmacy (503A or 503B) or, for FDA-approved peptides, a retail pharmacy. Compounding pharmacies vary significantly in quality, pricing, and turnaround time. Look for pharmacies that provide Certificates of Analysis (COAs) for their compounds, are PCAB accredited, and have transparent pricing.
Understand your protocol
Your prescriber will provide a protocol that includes the peptide(s), dose, frequency, route of administration, and cycle length. If your peptide arrives as a lyophilized powder, you will need to reconstitute it before use. Follow your prescriber's dosing instructions exactly — do not self-adjust doses without consulting them.
Monitor and follow up
Peptide therapy is not set-and-forget. Your prescriber will schedule follow-up labs (typically at 4-8 weeks) to assess your response and adjust the protocol as needed. Track how you feel subjectively, but rely on objective biomarker data to guide decisions about dose adjustments, continuing, or stopping therapy.
The cost of peptide therapy depends on the peptide, the source, and whether insurance covers any portion. Here are the general price ranges as of 2026.
| Category | Compounded | Brand-Name |
|---|---|---|
| GLP-1 Agonists (monthly) | $150 - $500 | $800 - $1,500+ |
| GH Secretagogues (monthly) | $100 - $300 | N/A (compounded only) |
| Recovery Peptides (per vial) | $40 - $150 | N/A (compounded only) |
| Cognitive Peptides (monthly) | $60 - $200 | N/A (compounded only) |
| Immune Peptides (monthly) | $100 - $250 | N/A (compounded only) |
| Prescriber Consultation | $100 - $300 | $100 - $300 |
Most peptide therapy is not covered by insurance, with the exception of FDA-approved formulations like brand-name semaglutide and tirzepatide when prescribed for approved indications (type 2 diabetes, obesity). Compounded peptides are almost never covered by insurance.
Prices vary significantly between pharmacies. Use our price comparison tool to see current pricing across multiple vendors.
Compare peptide prices across pharmaciesWe built these tools to help you navigate peptide therapy with better data and fewer errors.
Reconstitution Calculator
Calculate concentration and exact syringe units for your dose
COA Scanner
Upload a Certificate of Analysis and verify purity and identity
Price Comparison
Compare peptide pricing across compounding pharmacies
Protocol Builder
Build and track your peptide protocol with biomarker monitoring
Peptide Database
Profiles with dosing, mechanisms, biomarkers, and references
Reconstitution Guide
Step-by-step guide to mixing peptides with bacteriostatic water
The regulatory environment for peptide therapy is evolving rapidly. Understanding the current landscape is important for both patients and prescribers.
The FDA regulates peptides as drugs. Some peptides have full FDA approval (semaglutide, tirzepatide, bremelanotide), meaning they have been through Phase I-III clinical trials and are manufactured by pharmaceutical companies under strict GMP standards. Most peptides used in therapy, however, are dispensed through compounding pharmacies, which operate under different regulatory frameworks.
503A pharmacies are traditional compounding pharmacies that prepare medications based on individual patient prescriptions. They are regulated primarily by state boards of pharmacy. 503B outsourcing facilities can produce larger batches without individual prescriptions and are registered with and inspected by the FDA. 503B facilities are generally held to higher manufacturing standards, including more rigorous testing and quality controls.
The FDA has been categorizing bulk drug substances used in compounding into Category 1 (those with an established safety profile that are suitable for compounding) and Category 2 (those that have been nominated for evaluation). This classification directly affects which peptides compounding pharmacies can legally prepare. Changes to these lists can remove peptides from the compounding market, which is why staying informed about regulatory updates is critical.
The regulatory landscape changes frequently. Peptides that are available through compounding pharmacies today may be restricted tomorrow based on FDA rulemaking. Always verify current availability with your prescriber and pharmacy.
Peptide therapy refers to the use of specific short-chain amino acid sequences (peptides) to target particular biological pathways in the body. Unlike broad-spectrum medications, peptides are designed to interact with specific receptors — such as GLP-1 receptors for metabolic regulation or growth hormone releasing hormone receptors for GH secretion. Peptide therapy is prescribed by licensed healthcare providers and dispensed through compounding pharmacies or as FDA-approved formulations.
Some peptides are FDA-approved drugs — for example, semaglutide (Ozempic/Wegovy) for diabetes and weight management, and bremelanotide (Vyleesi/PT-141) for hypoactive sexual desire disorder. Many other peptides used in therapy are dispensed through 503A or 503B compounding pharmacies under a prescriber's order, which is a legal pathway but distinct from direct FDA approval of the compound itself. The regulatory landscape continues to evolve, particularly around compounded GLP-1 agonists and Category 1/Category 2 classifications.
The most common route is subcutaneous injection using a small insulin syringe, typically in the abdominal area or thigh. Some peptides are available as nasal sprays (such as Semax and Selank), oral capsules (such as BPC-157 for gut-focused protocols), or topical creams (such as GHK-Cu for skin applications). The route of administration affects bioavailability — injectable peptides generally have the highest absorption rates.
Costs vary widely depending on the peptide, the pharmacy, and whether you use a compounding pharmacy or a brand-name formulation. Common research peptides like BPC-157 and TB-500 can range from $40-$150 per vial from a compounding pharmacy. GLP-1 agonists like compounded semaglutide may range from $150-$500 per month, while brand-name versions (Ozempic, Wegovy) can exceed $1,000 per month without insurance. Prescriber consultations typically cost $100-$300 for the initial visit.
Side effects vary by peptide. GLP-1 agonists commonly cause nausea, especially during dose titration. Growth hormone secretagogues may cause water retention, joint stiffness, or elevated fasting glucose. BPC-157 and TB-500 have relatively few reported side effects in the available literature. All peptides carry some risk, which is why therapy should be supervised by a licensed healthcare provider who can monitor relevant biomarkers.
Yes. Legitimate peptide therapy requires a prescription from a licensed healthcare provider — typically a physician, nurse practitioner, or physician assistant. The prescriber evaluates your health history, orders baseline labs, writes the prescription, and monitors your progress. The prescription is filled by a compounding pharmacy (503A or 503B) or, for FDA-approved peptides, a standard retail pharmacy.
Response timelines vary by peptide and goal. GLP-1 agonists for weight loss typically show measurable results within 4-8 weeks of reaching a therapeutic dose. Growth hormone secretagogues may take 8-12 weeks to produce noticeable changes in body composition and sleep quality. Recovery peptides like BPC-157 are often reported to show effects within 2-4 weeks. Longevity peptides like Epithalon are cycled over months to years and are tracked through biomarkers rather than subjective symptoms.
Yes, many prescribers use peptide combinations (stacks) where the compounds target complementary pathways. Common examples include BPC-157 + TB-500 for recovery, CJC-1295 + Ipamorelin for growth hormone release, and Semax + Selank for cognitive support. Stacking should always be done under prescriber supervision to monitor for interactions and to track biomarkers appropriately.
Brand-name peptides (like Ozempic or Wegovy) are manufactured by pharmaceutical companies, have undergone full FDA clinical trials, and are dispensed through retail pharmacies. Compounded peptides are prepared by 503A or 503B compounding pharmacies based on a prescriber's order. Compounding pharmacies can produce peptides that are not commercially available or are in shortage, often at lower cost. The trade-off is that compounded formulations do not go through the same FDA approval process as brand-name drugs.
Baseline labs depend on the peptide. For GLP-1 agonists, prescribers typically order HbA1c, fasting glucose, insulin, a lipid panel, and liver enzymes. For growth hormone secretagogues, IGF-1, fasting glucose, and HbA1c are standard. For recovery peptides, CRP, IL-6, and a basic metabolic panel are common. A comprehensive metabolic panel and CBC are reasonable baselines for any peptide protocol. Your prescriber will tailor the lab panel to your specific protocol.
Find a qualified prescriber, compare pharmacy pricing, or explore our peptide database to learn more about specific compounds.
This guide is for educational purposes only. It is not medical advice. Consult a licensed healthcare provider before using any peptide. Peptide therapy should only be pursued under the supervision of a qualified prescriber who can order appropriate lab work and monitor your response.
Disclosed Labs